Cilengitide trifluoroacetate salt,CAS : 188968-51-6
Cyclo(-Arg-Gly-Asp-D-Phe-N-Me-Val) trifluoroacetate salt
Product description
The cyclic RGD peptide cilengitide is a potential cancer drug. Cilengitide is under investigation for the treatment of glioblastoma, where it may act by inhibiting angiogenesis, and influencing tumor invasion and proliferation.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >90% |
Solubility | N/A |
Cas | 188968-51-6 |
Sequence | c(RGDf(Me)V) |
Molecular Formula | C₂₇H₄₀N₈O₇ |
Storage | -20℃,protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product